The Japanese conglomerate is in talks to spend up to $43 billion to boost the ChatGPT developer.
President Trump has threatened to impose tariffs on Canada over drug trafficking, equating it with Mexico. U.S. government reports do not support the claim.
Shares of Cipher Mining were trading higher in the after-hours market following news of a $50 million private investment in public equity deal from SoftBank Group. After the bell Thursday, shares of Cipher Mining rose 19% to trade at $5.60. The stock finished the day's regular session with a 4.4% gain, closing at $4.70.
Cipher Mining Inc. (NASDAQ: NASDAQ:CIFR) shares climbed 20% following the announcement of a significant investment by SoftBank (TYO:9984) Group Corp., indicating a strong market response to the new partnership.
Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today announced a $50 million investment from SoftBank Group Corp.(TSE: 9984, “ SoftBank ”), one of the world’s most prominent investment holding companies.
SoftBank is in talks to invest in OpenAI, potentially deepening the relationship between the two companies that are already planning an artificial-intelligence infrastructure initiative.
Just about a week after the White House announced its new AI Stargate Project, two of the venture's biggest names may become even closer partners. SoftBank reportedly is looking to invest between $15 billion and $25 billion into OpenAI,
OpenAI is in talks for an investment round to raise nearly $40 billion that would value the AI startup at up to $340 billion, the Wall Street Journal reported on Thursday.
A new investment from the Japanese conglomerate would be separate from the $100 billion tied to a project announced at the White House last week.
Japanese investment conglomerate SoftBank (SFTBY) intends to invest up to $40 billion in OpenAI, leaving another initial backer, Microsoft
Some of the funding would be used to help cover OpenAI’s $18 billion commitment to the recently announced Stargate project.
A professor and his team at University of the Pacific have developed a single-dose treatment that provides extended protection against opioid overdoses.